急性普马拉汉坦病毒感染期间非相关类毒素免疫的异源加强效应
该研究纳入45例急性普马拉汉坦病毒感染患者,检测其对破伤风、白喉和百日咳类毒素疫苗抗原的T细胞和抗体应答。发现破伤风和百日咳特异性IgG浓度在急性感染期升高,且升高与异源T细胞增殖相关;破伤风特异性IgG升高持续至感染后一年,而百日咳特异性IgG迅速下降。结果提示异源加强可促进旧免疫记忆的维持,且不同类毒素抗原可能被区别对待。
要点
- 急性普马拉汉坦病毒感染可非特异性地升高破伤风和百日咳特异性IgG。
- 疫苗IgG升高与异源T细胞增殖相关联。
- 破伤风IgG升高持续一年,百日咳IgG迅速下降,动力学不同。
核心结论
- 异源加强旧免疫记忆可能促进免疫记忆的持久性。
- 不同类毒素抗原在异源免疫影响下可能被区别对待。
- 异源免疫可能影响疫苗接种结局。
研究设计与样本
- 队列研究,纳入45例急性普马拉汉坦病毒感染患者。
- 检测针对破伤风、白喉和百日咳类毒素疫苗抗原的T细胞和抗体应答。
主要发现
- 破伤风特异性IgG浓度在急性普马拉汉坦病毒感染期间升高。
- 百日咳特异性IgG浓度在急性感染期间升高。
- 疫苗IgG升高与异源T细胞增殖相关。
- 破伤风特异性IgG升高在感染后一年仍持续。
- 百日咳特异性IgG在感染后迅速下降。
临床怎么用
- 提示急性病毒感染期间可能非特异性影响既往疫苗抗体水平,解读抗体结果时需考虑此背景。
- 不同类毒素疫苗抗原的抗体动力学可能不同,随访策略可据此调整。
- 异源免疫效应可能影响疫苗接种效果的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Persistence of immune memory in humans is a crucial yet poorly understood aspect of immunology. Here we have studied the effect of Puumala hantavirus infection on unrelated, pre-existing immune memory by studying T cell- and antibody responses against toxoid vaccine antigens of diphtheria, tetanus and pertussis in a cohort of 45 patients. We found that tetanus- and pertussis -specific IgG concentrations elevate during acute Puumala virus infection. Increase in vaccine IgG was associated with proliferation of heterologous T cells. Interestingly, increases in tetanus-specific IgG persisted a year after the infection while pertussis-specific IgG declined rapidly; a difference in IgG kinetics resembling the difference seen after vaccination against tetanus and pertussis. These results suggest that persistence of immune memory is facilitated by heterologous boosting of old memory during memory formation against newly encountered antigens. They also show that different toxoid antigens may be treated differently. Our study gives new insight into how immune memory formation may alter pre-existing immune memory, and also shows that heterologous immunity may have an impact on vaccination outcomes.
引用
- Lamponen T, Hetemäki I, Niemi HJ, et al. Heterologous boosting of nonrelated toxoid immunity during acute Puumala hantavirus infection. Vaccine. 2021. PMID: 33678453. doi:10.1016/j.vaccine.2021.02.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。